In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
SBS’s new Friday–Saturday drama “No Tail to Tell” has unveiled a new teaser! “No Tail to Tell” is a fantasy romance starring Kim Hye Yoon as Eun Ho, a quirky Gen Z gumiho (a magical nine-tailed fox) ...
Hosted on MSN
Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships
CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results